Signaling pathways of prohibitin and its role in diseases.
about
Chaperones in hepatitis C virus infectionMultifaceted role of prohibitin in cell survival and apoptosisEffect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes.Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways.Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytesQuantitative proteomics identifies host factors modulated during acute hepatitis E virus infection in the swine model.Potential signal pathway of all-trans retinoic acid for MMP-2 and MMP-9 expression in injury podocyte induced by adriamycin.Adriamycin resistance-associated prohibitin gene inhibits proliferation of human osteosarcoma MG63 cells by interacting with oncogenes and tumor suppressor genes.Akt phosphorylates Prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cellsAssociation of peroxisome proliferator-activated receptors/retinoic acid receptors with renal diseases.Role of poly (ADP-ribose)-polymerase and its signaling pathway with renin-angiotensin aldosterone system in renal diseases.Role of toll-like receptors gene polymorphism in renal transplantation.Role of toll-like receptors gene polymorphism in hepatocellular carcinoma.Role of toll-like receptors in lung cancer.Role of high mobility group box 1 and its signaling pathways in renal diseases.Role of toll-like receptors in myocardial infarction.Signalling pathways involved in the process of mesenchymal stem cells differentiating into hepatocytes.Identification of prohibitin 1 as a potential prognostic biomarker in human pancreatic carcinoma using modified aqueous two-phase partition system combined with 2D-MALDI-TOF-TOF-MS/MS.Association of dialysate calcium concentration with fetuin A level and carotid intima-media thickness in peritoneal dialysis patients.Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.Inhibition of the CRAF/prohibitin interaction reverses CRAF-dependent resistance to vemurafenib.Characterization of Prohibitin 1 as a Host Partner of Vibrio vulnificus RtxA1 Toxin.Prohibitin is associated with antioxidative protection in hypoxia/reoxygenation-induced renal tubular epithelial cell injury.Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment.Mitochondrial prohibitin and its ubiquitination during crayfish Procambarus clarkii spermiogenesis.Association of prohibitin-1 and 2 with oxidative stress in rats with renal interstitial fibrosis.Cancer risk susceptibility loci in a Swedish population.Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway.Characterization of mitochondrial prohibitin from Boleophthalmus pectinirostris and evaluation of its possible role in spermatogenesis.Lamprey Prohibitin2 Arrest G2/M Phase Transition of HeLa Cells through Down-regulating Expression and Phosphorylation Level of Cell Cycle Proteins.The potential signaling pathway between peroxisome proliferator-activated receptor gamma and retinoic acid receptor alpha in renal interstitial fibrosis disease.Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment.Exploring novel key regulators in breast cancer network.
P2860
Q26771251-3273BFF0-E479-4042-8BC0-BBCB5E7287EBQ28087391-88151EB0-1F34-4DF4-A259-9EF48C22A1AAQ30388470-AD1A7651-BD83-413E-ACCF-B7BB55DA4E6AQ33587501-7ACC65F3-ADAF-4249-8CBD-3C1FC540938BQ34234115-56310416-8B29-4C4F-8F49-039D8DAFE4DCQ34992525-35EB342D-8C23-4DB8-BA31-5A626BF1AFCFQ35138010-75110CD7-D3EE-4A0C-B624-1F3E022ECFD5Q36124937-1DDA8AEB-FA3F-4B54-BB0E-3475C6644528Q36347268-5535FDDA-57BE-40BD-82CC-40D2A36DAF88Q38139624-5CFD603B-6180-4BF5-A45F-F7015C5F4FA6Q38168567-E9B004FC-901C-4238-9060-9A8DB3D599B5Q38168874-319452A9-B6C1-42A1-8D12-F4D09871CDC3Q38196949-5DF3B66A-F5E9-496E-9383-983FCA073F6CQ38196950-0E391DA3-7992-4746-9EB7-6B5DC89D4BF2Q38199750-0CD4DCB5-B488-4EF0-A04B-2CE7C940FCA7Q38291083-F5A26195-E463-405C-8F6B-6DAAFC975458Q38346070-A18F88F2-3417-4704-A7B6-2E467D6A1390Q38471197-14617197-27ED-4552-A930-DBB6E5FB37B5Q39351638-01733223-0881-4B27-AAAD-396E216E6E5CQ39514941-39049728-864E-40D7-A505-5B51699EF51FQ39671585-BB0FC451-A42C-4B75-A1F4-1043CECC7F81Q41127200-24113A10-2059-4E81-84CD-CDB93AAFFF9EQ42923310-E2196A14-3699-48FB-A459-C4DF39282ADAQ43185293-FB7D6939-3919-4935-871B-5FDC1B31C007Q46811294-B0BF7044-A2AA-4B02-BAEC-3B30B0E09777Q46923795-576CA850-D8E0-4DEF-8907-DFACC61FC256Q47159601-34AA4BAE-B5EB-4AEC-9782-09C26A0DE34EQ48357636-466F2ED9-72FC-41AC-AF1D-C3701D2F44B7Q49164012-7973C4A2-C46A-4BF8-8895-3832AC2EC9F0Q50649721-2B257CE1-9A77-4C50-B5BF-BBE6C56E9314Q51745042-B037EFF1-2F88-46A2-B996-8DE2669F698CQ53007399-E0B741E4-509D-4AA6-A90F-4FBB2F8EE498Q55253157-B788C8EE-0102-4B25-93B2-53478FD9665FQ55496631-A57129C1-8EC9-4B46-AC90-6A618F75EE99
P2860
Signaling pathways of prohibitin and its role in diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Signaling pathways of prohibitin and its role in diseases.
@en
type
label
Signaling pathways of prohibitin and its role in diseases.
@en
prefLabel
Signaling pathways of prohibitin and its role in diseases.
@en
P2860
P1476
Signaling pathways of prohibitin and its role in diseases.
@en
P2093
Tian-Biao Zhou
Yuan-Han Qin
P2860
P356
10.3109/10799893.2012.752006
P577
2013-01-18T00:00:00Z